Codexis, Inc. (NASDAQ:CDXS) Receives $19.83 Average PT From Analysts
Codexis, Inc. (NASDAQ:CDXS) Receives $19.83 Average PT From Analysts
Codexis, Inc. (NASDAQ:CDXS – Get Rating) has earned an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $19.83.
据MarketBeat报道,纳斯达克公司(Codexis,Inc.)(股票代码:CDXS-GET Rating)目前负责该股的八位分析师平均推荐该公司“适度买入”。一名分析师对该股的评级为持有,三名分析师对该公司的评级为买入。在去年发布该股报告的券商中,12个月目标价的平均水平为19.83美元。
Several equities research analysts recently weighed in on CDXS shares. HC Wainwright reduced their price target on shares of Codexis from $25.00 to $15.00 and set a "buy" rating on the stock in a research report on Monday, November 7th. StockNews.com raised shares of Codexis from a "sell" rating to a "hold" rating in a research note on Tuesday. Finally, Piper Sandler lifted their price objective on shares of Codexis from $22.00 to $23.00 and gave the stock an "overweight" rating in a research note on Thursday, January 19th.
几位股票研究分析师最近纷纷买入CDX股票。在11月7日星期一的一份研究报告中,HC Wainwright将Codexis的股票目标价从25.00美元下调至15.00美元,并将该股的评级定为“买入”。在周二的一份研究报告中,StockNews.com将Codexis的股票评级从“卖出”上调至“持有”。最后,派珀·桑德勒将Codexis股票的目标价从22.00美元上调至23.00美元,并在1月19日星期四的一份研究报告中给出了该股“增持”的评级。
Insider Activity
内幕活动
In other news, Director John J. Nicols sold 35,714 shares of the business's stock in a transaction on Monday, December 12th. The shares were sold at an average price of $5.68, for a total transaction of $202,855.52. Following the completion of the sale, the director now directly owns 863,535 shares of the company's stock, valued at $4,904,878.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director John J. Nicols sold 39,785 shares of the business's stock in a transaction on Friday, December 9th. The shares were sold at an average price of $5.66, for a total transaction of $225,183.10. Following the completion of the sale, the director now directly owns 863,535 shares of the company's stock, valued at $4,887,608.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director John J. Nicols sold 35,714 shares of the business's stock in a transaction on Monday, December 12th. The shares were sold at an average price of $5.68, for a total transaction of $202,855.52. Following the sale, the director now directly owns 863,535 shares of the company's stock, valued at $4,904,878.80. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 111,213 shares of company stock valued at $657,323. 7.00% of the stock is currently owned by company insiders.
在其他新闻方面,董事约翰·J·尼科尔斯在12月12日(星期一)的一次交易中出售了35,714股该公司股票。这些股票以5.68美元的平均价格出售,总成交金额为202,855.52美元。出售完成后,董事现在直接持有该公司863,535股股票,价值4,904,878.80美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,该文件可以通过美国证券交易委员会网站。其他消息方面,董事约翰·J·尼科尔斯在12月9日(星期五)的一次交易中出售了39,785股该公司股票。这些股票的平均价格为5.66美元,总成交金额为225,183.10美元。出售完成后,董事现在直接持有该公司863,535股股票,价值4887,608.10美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的,该文件可以通过美国证券交易委员会网站。此外,董事约翰·J·尼科尔斯在12月12日(星期一)的一次交易中出售了35,714股该公司股票。这些股票以5.68美元的平均价格出售,总成交金额为202,855.52美元。交易完成后,董事现在直接持有该公司863,535股股票,价值4904,878.80美元。关于这次销售的披露可以找到这里。在过去的90天里,内部人士抛售了111,213股公司股票,价值657,323美元。7.00%的股份目前由公司内部人士持有。
Institutional Trading of Codexis
Codexis的机构性交易
Codexis Trading Down 3.7 %
Codexis股价下跌3.7%
CDXS opened at $6.45 on Monday. The company has a market cap of $423.70 million, a price-to-earnings ratio of -13.44 and a beta of 1.56. The company's 50 day moving average is $5.58 and its 200 day moving average is $6.28. Codexis has a 12-month low of $4.21 and a 12-month high of $22.22.
CDX周一开盘报6.45美元。该公司市值为4.237亿美元,市盈率为-13.44倍,贝塔系数为1.56。该公司的50日移动均线切入位在5.58美元,200日移动均线切入位在6.28美元。Codexis的12个月低点为4.21美元,12个月高位为22.22美元。
Codexis (NASDAQ:CDXS – Get Rating) last announced its quarterly earnings results on Thursday, November 3rd. The biotechnology company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.03. Codexis had a negative net margin of 23.49% and a negative return on equity of 19.59%. The company had revenue of $34.47 million for the quarter, compared to analysts' expectations of $31.41 million. As a group, analysts predict that Codexis will post -0.56 EPS for the current fiscal year.
纳斯达克(股票代码:CDXS-GET Rating)上一次公布季度收益是在11月3日(星期四)。这家生物技术公司公布了本季度每股收益(0.15美元),比普遍预期的(0.18美元)高出0.03美元。Codexis的净利润率为负23.49%,股本回报率为负19.59%。该公司当季营收为3,447万美元,高于分析师预期的3,141万美元。分析师预测,作为一个整体,Codexis本财年的每股收益将达到0.56欧元。
About Codexis
关于Codexis
(Get Rating)
(获取评级)
Codexis, Inc is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market.
Codexis,Inc.是一家从事治疗药物开发和销售的酶工程公司。它通过性能酶和新的生物疗法部门进行运作。性能酶部门在药品市场上商业化CodeEvolver蛋白质工程技术平台和产品。
Recommended Stories
推荐故事
- Get a free copy of the StockNews.com research report on Codexis (CDXS)
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
- Ford Stock Going Forward After Big Earnings Flop
- Insiders And Institutions Buy Wolverine Worldwide
- 免费获取StockNews.com关于Codexis的研究报告(CDXs)
- 细价股值得吗?你应该投资细价股吗?
- Zimmer Biomet盈利节节攀升,增长可能被计入价格
- 人工智能软件制造商EPAM号称科技板块涨幅最大
- 福特股票在盈利大幅下滑后继续前进
- 内部人士和机构收购金刚狼全球
Receive News & Ratings for Codexis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Codexis and related companies with MarketBeat.com's FREE daily email newsletter.
接受Codexis Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Codexis和相关公司的最新新闻和分析师评级的每日简要摘要。